Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Trelleborg – page 24

453 clinical trials in Trelleborg, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Trelleborg at a glance
453
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

453 trials in Trelleborg

Open in trial search

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol Sulfate
  • Sponsor:AstraZeneca AB

A Study to Test the Long-term Safety and Benefits of GSK4527226 in Patients with Early Alzheimer's Disease

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:GSK4527226
  • Sponsor:Glaxosmithkline Research & Development Limited

A Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Mezagitamab
  • Sponsor:Takeda Development Center Americas Inc.

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Breast cancer+1

Not recruiting

Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB

Arteriosclerosis

Not recruiting

Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Study of zorevunersen to reduce seizures in patients with Dravet syndrome

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Zorevunersen sodium
  • Sponsor:Stoke Therapeutics Inc.

Study of laroprovstat (AZD0780) tablets to lower cholesterol levels in adults with inherited high cholesterol condition (heterozygous familial hypercholesterolemia)

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

COVID-19

Not recruiting

Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ibuzatrelvir
  • Sponsor:Pfizer Inc.

Safety and immunogenicity study of Pentavalent Meningococcal ABCYW vaccine (MenPenta SD and MenPenta fHD) compared to licensed meningococcal vaccines in infants, toddlers and children

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · Healthy volunteers
  • Substances:Diphtheria toxoid
  • Sponsor:Sanofi Pasteur Inc.

Anhedonia

Not recruiting

Study on Pramipexole for Reducing Anhedonia in Patients with Major Depression

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Pramipexole
  • Sponsor:Region Skane

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Trelleborg

What the registry says about research in the country

01 Analytical and Diagnostic Research

Clinical trial activity in Trelleborg includes analytical and diagnostic research focused on better understanding treatment response and patient outcomes in everyday practice.

  • Assessment of symptom improvement in allergic rhinitis due to dog allergy
  • Monitoring clinical response to allergen-specific vaccination
  • Evaluation of outcome measures used to track effectiveness in routine care

These studies aim to improve how clinicians identify benefit and measure changes in patients over time.

02 Allergy and Immune System Diseases

One major focus is immune system diseases, especially allergic rhinitis due to dog allergy, with research designed to test whether targeted allergy treatment can reduce symptoms and improve quality of life.

  • Dog allergy and related nasal symptoms
  • Allergen immunotherapy in real-world Swedish practice
  • Long-term relief of allergy-related discomfort

This work explores the effectiveness of a new approach for helping patients manage persistent allergy symptoms.

03 Musculoskeletal Diseases

Another key area is musculoskeletal diseases, particularly research linked to hip arthroplasty and prevention of prosthetic joint infection.

  • Prosthetic Joint Infection after joint replacement
  • Strategies to lower infection risk following hip replacement
  • Support for safer recovery in orthopedic care

The goal is to evaluate whether infection-preventing bone graft treatment can improve outcomes after surgery.

04 Bacterial Infections and Surgical Procedures

Research in bacterial infections and surgical procedures is centered on preventing post-operative complications and improving the success of orthopedic treatment.

  • Prevention of infection in bone graft use
  • Protection against bacteria-related complications after surgery
  • Testing a treatment approach designed to support surgical recovery

These trials help clarify whether infection-focused interventions can make operative care safer and more effective.

05 Musculoskeletal and Neural Physiological Phenomena

The local research profile also reflects interest in musculoskeletal and neural physiological phenomena, with clinical studies examining how the body responds to allergy treatment and orthopedic interventions.

  • Changes in symptoms and function over time
  • Patient response after allergen treatment
  • Recovery patterns following joint replacement

In Trelleborg, these studies aim to connect physiological changes with practical benefits for patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.